Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York, USA.
Department of Population Health Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
AIDS Patient Care STDS. 2020 Sep;34(9):380-391. doi: 10.1089/apc.2020.0062.
Prior research found low acceptability of HIV treatment as prevention (TasP; or ) among HIV-negative men who have sex with men (MSM). This study reports on qualitative data regarding TasP adoption in a sample of 170 self-reported HIV-negative MSM who had engaged in exchange sex (received money, drugs, or other things in exchange for sex). We classified participants along five stages of TasP adoption: 1-unaware of TasP (11.2%); 2-aware, but perceived ineffective (17.1%); 3-perceived effective, but unwilling to use (35.3%); 4-willing to rely on TasP, but had never done so (24.1%); and 5-had relied on TasP (12.4%). Obstacles to TasP adoption included the following: not believing that it could completely prevent HIV transmission; deeply ingrained fears of HIV/AIDS; concerns about viral load fluctuation; and reluctance to trust a partner's claimed undetectable status. TasP promotion efforts, which can decrease barriers to HIV testing and HIV stigma, will be more effective if tailored to the obstacles specific to each stage of TasP adoption.
先前的研究发现,艾滋病毒阴性的男男性行为者(MSM)对艾滋病毒治疗作为预防(TasP;或)的接受程度较低。本研究报告了一项针对 170 名自我报告的艾滋病毒阴性的 MSM 中 TasP 采用情况的定性数据,这些 MSM 曾从事过性交换(用性换取金钱、毒品或其他物品)。我们根据 TasP 采用的五个阶段对参与者进行了分类:1. 不知道 TasP(11.2%);2. 知道,但认为无效(17.1%);3. 认为有效,但不愿意使用(35.3%);4. 愿意依赖 TasP,但从未这样做过(24.1%);5. 已经依赖 TasP(12.4%)。TasP 采用的障碍包括以下几个方面:不相信它可以完全预防艾滋病毒传播;对艾滋病毒/艾滋病根深蒂固的恐惧;对病毒载量波动的担忧;以及不愿意相信伴侣声称的未检测状态。如果 TasP 推广工作能够针对每个 TasP 采用阶段的具体障碍进行定制,那么减少 HIV 检测和 HIV 污名化的障碍将更加有效。